Chinese car brand LDV is fighting the consumer regulator’s case alleging it misled customers about its vehicles, telling a court that ads showing the vehicles as durable in off-road terrains were not misleading.
The Full Federal Court will hear developer Robert Filippini’s appeal of freezing orders won by Keystone Asset Management’s liquidators, as ASIC’s investigation of Keystone’s failed Shield fund ramps up.
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
The Foreign Investment Review Board has extended the deadline for ruling on Cosette’s proposed $672 million takeover of Mayne Pharma.
John Holland has persuaded a court to limit an expert determination in a dispute with contractor Downer EDI over the construction of a rollingstock manufacturing facility in Torbanlea, Queensland.
The Takeovers Panel has agreed to hear Mayne Pharma’s latest dispute with Cosette over the US drug maker’s attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
The director of collapsed Shangri-La Construction is personally liable for the $3.2 million in costs of rectification work on external cladding at an apartment complex in southeast Melbourne, a judge has found.
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
In its case accusing Australian Gas Networks of greenwashing with ads promising gas was “becoming renewable”, the consumer regulator is pushing the company to identify who it says had reasonable grounds for the statements.